PHATHOM PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2018 | 100.2% | 100.2% | -142.8% |
| FY2019 | -111.9% | -101.8% | -99.2% |
| FY2020 | -66.4% | -55.2% | -43.7% |
| FY2021 | -199.4% | -88.9% | -76.0% |
| FY2022 | 264.3% | -966.9% | -120.0% |
| FY2023 | 277.1% | -309.7% | -48.7% |
| FY2024 | 131.8% | 640.8% | -88.4% |
| FY2025 | 50.5% | 96.6% | -85.4% |